American Journal of Clinical Dermatology
American Journal of Clinical Dermatology (commonly abbreviated Am. J. Clin. Dermatol.) is a bimonthly dermatology journal published in Auckland by Adis International of New Zealand, part of Springer, built around evidence-based therapy and effective patient management, with manuscripts written in English.American Journal of Clinical Dermatology（常用缩写 Am. J. Clin. Dermatol.）是由施普林格（Springer）旗下 Adis International（新西兰）在奥克兰出版的皮肤病学双月刊，以循证治疗与有效患者管理为办刊核心，稿件以英文为主
Scope
The mission stated on the journal website is to promote evidence-based therapy and effective patient management within dermatology, publishing critical and comprehensive review articles and clinically focused original research articles covering all aspects of the management of dermatological conditions.期刊官网公布的办刊宗旨是推动皮肤病学学科内的循证治疗与有效患者管理，主要刊载批判性且全面的综述文章以及以临床为着眼点的原创研究论文，涵盖皮肤病况管理的各个方面[1]
- Definitive reviews: authoritative reviews on the management of dermatological conditions, concentrating on the place in therapy of newer and established agents and procedures.权威综述： 刊载针对皮肤病况管理的定论性综述，重点讨论新型与既有药物及操作方法在治疗中所处的地位
- Evidence-based systematic reviews: systematic reviews of a specific disease or therapeutic question that critically appraise the available published literature and make the strength of the evidence explicit.循证系统综述： 刊载针对某一特定疾病或治疗问题的系统综述，对已有文献作出批判性评估，明确各证据的强弱
- Leading and current opinion articles: overviews of contentious or emerging areas, setting out relevant research progress alongside key regulatory and ethical issues.观点类文章： 刊载针对争议性议题或新兴领域的综述，概述相关的研究进展与关键的监管和伦理问题
- Therapy in practice reviews: clinically oriented reviews setting out optimal management of specific conditions for direct use by front-line clinicians.实践中的治疗： 刊载面向临床的实践型综述，归纳特定病症的最佳管理方案，供一线医生直接参考
- Original research and drug evaluations: original research articles of clinical importance, together with an Adis Drug Evaluations column written by in-house writers and reviewed by a panel of external experts, systematically assessing the properties of dermatological drugs and their place in therapy.原创研究与药物评价： 刊载具有临床意义的原创研究论文，并设有 Adis Drug Evaluations 专栏，由内部撰稿人执笔、外部专家评审，系统评价皮肤科药物的性质与治疗地位
Taken as a whole, this is a service-oriented journal in which reviews form the body and original research the supplement, and it is one of the few specialist titles in dermatology that serves both the rapid decision needs of clinicians and the literature-review needs of researchers. It operates a hybrid open access model, charging no publication fee on the traditional subscription route, while allowing authors to publish open access where their funders require it.总体而言，该刊以综述为主体、原创研究为补充的服务型期刊形态，是皮肤病学领域少数能同时满足临床医生快速决策与研究者文献综述需求的专业刊物；其采用混合开放获取模式，走传统订阅路线不向作者收取版面费，但作者可在资助方要求时选择以开放获取方式发表
History
- 2000: founding. the journal was founded in 2000 by Adis International, based in Auckland, New Zealand, and from the outset adopted an editorial style in which drug and therapy evaluations were written by in-house teams and reviewed by external experts.2000年：创刊。 该刊于 2000 年创刊，由总部设在新西兰奥克兰的 Adis International 出版，创刊之初即确立了以独立撰稿团队加外部专家评审方式来写作药物与治疗评价的编辑风格
- 2000 to present: the title. the journal has kept the name American Journal of Clinical Dermatology throughout and has never been formally renamed, with a print ISSN of 1175-0561 and an electronic ISSN of 1179-1888.2000年至今：刊名未变。 该刊自创刊起一直沿用 American Journal of Clinical Dermatology 这一名称，从未正式更名，其印本 ISSN 为 1175-0561，电子版 ISSN 为 1179-1888
- An international board. members of the honorary editorial board come from the United States, the United Kingdom, Germany, France, Italy, Canada, Australia and Israel, and the board has long covered both general dermatology and dermatopathology.编辑阵容的国际化： 名誉编委会成员来自美国、英国、德国、法国、意大利、加拿大、澳大利亚与以色列等地，长期涵盖普通皮肤病学与皮肤病理学两大分支
- Steadily rising influence. the impact factor rose from 3.018 in 2018 to 11.4 in 2025, with a five-year impact factor of 10.7, making it one of the fastest-growing titles in dermatology.影响力持续攀升： 期刊影响因子由 2018 年的 3.018 起步，至 2025 年已升至 11.4，五年影响因子为 10.7，是皮肤病学领域增长最为迅猛的刊物之一
- Indexing and ranking. the journal is indexed in SCIE and is placed in the Q1 quartile for dermatology in the Journal Citation Reports. In the Chinese Academy of Sciences ranking it is a first-tier top journal in medicine with a first-tier dermatology subcategory, and the latest evaluation records no warning.收录与分区： 期刊被SCIE（科学引文索引扩展版）收录，在期刊引证报告中列于皮肤病学 Q1 区；在中国科学院期刊分区中为医学 1 区、皮肤病学小类 1 区 Top 期刊，最新评估未见预警记录
Editors
The editorial work is carried out by a dedicated team based in Auckland, New Zealand, comprising an Editor-in-Chief and several section editors, with academic quality assured by an honorary editorial board of dermatologists from around the world. Manuscripts are subject to peer review before an acceptance decision is made.该刊的编辑工作由设在新西兰奥克兰的专职团队承担，设执行主编一名与分区编辑数名，学术把关则依靠覆盖全球的皮肤科专家组成的名誉编委会，稿件经同行评审后决定录用
- Kathy A. Fraser is the current Editor-in-Chief, based at Adis International and Springer Nature, and is responsible for the journal's overall editorial direction and acceptance decisions.Kathy A. Fraser：现任执行主编，供职于 Adis International 与施普林格（Springer Nature），负责期刊的整体编辑方向与录用决策
- Section editors: Martin Chopra, Rod McNab and Dene Peters serve as section editors, all based at Adis International and each responsible for manuscripts in a different subject area.分区编辑： Martin Chopra、Rod McNab 与 Dene Peters 担任分区编辑，均供职于 Adis International，分别负责不同主题方向的稿件处理
- Honorary editorial board: this board is the core of the journal's academic quality control and is made up of dermatologists from major clinical institutions, among them Robert P. Dellavalle of the University of Minnesota in the United States, Amy S. Paller of Northwestern University in the United States, Joseph C. English III of the University of Pittsburgh in the United States, Christopher E. M. Griffiths of the University of Manchester in the United Kingdom, Rod J. Hay of King's College London in the United Kingdom, and Brigitte Dréno of the University of Nantes in France.名誉编委会： 该委员会是刊物学术把关的核心，成员多为知名临床机构的皮肤病学专家，例如来自明尼苏达大学（美国）的 Robert P. Dellavalle、来自西北大学（美国）的 Amy S. Paller、来自匹兹堡大学（美国）的 Joseph C. English III、来自曼彻斯特大学（英国）的 Christopher E. M. Griffiths、来自伦敦国王学院（英国）的 Rod J. Hay，以及来自南特大学（法国）的 Brigitte Dréno
- Full roster and submission information: the complete honorary editorial board, the editorial policies and the instructions for authors are given on the journal's official page.完整名单与投稿信息： 名誉编委会全体成员、编辑政策与投稿须知见期刊官方页面[2]